Conjunctivitis historical perspective

Jump to navigation Jump to search

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis historical perspective

CDC on Conjunctivitis historical perspective

Conjunctivitis historical perspective in the news

Blogs on Conjunctivitis historical perspective

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Conjunctivitis is an ancient disease, and was first described by S.T. Quellmaz.[1] In 1881, Crédé introduced 2% silver nitrate for the first time as a prophylaxis treatment method for conjunctivitis in the newborns in Leipzig.[2]

Historical Perspective

  • In 1750, neonatal conjunctivitis (ophthalmia neonatorum) was first described by S.T. Quellmaz.[1]
  • In 1881, Crédé introduced 2% silver nitrate for the first time as a prophylaxis treatment method for conjunctivitis in the newborns in Leipzig.[2]
  • In 1883, Koch discovered the bacilli of two different forms of infectious conjunctivitis or Egyptian ophthalmia.
  • In 1886, Weeks discovered the same organism to be the cause of pink eye.[3]
  • In 1953, Micheal Hogan first described the association between atopic dermatitis and conjunctival inflammation.[4]
  • In 1963, Thygeson and Kimura first described superior limbic keratoconjunctivitis as a chronic, localized, filamentary conjunctivitis, and later this condition was given its name, superior limbic keratoconjunctivitis, by Theodore.[5]
  • In 1968, Tenzel and Corwin were the first to discover the association between thyroid abnormalities and development of superior limbic keratoconjunctivitis.[6]
  • In 1969, acute hemorrhagic conjunctivitis was first described as occurring in Ghana.[7]
  • Between 1981-2003, four major epidemics of acute hemorrhagic conjunctivitis had occurred in the Western Hemisphere.[8]
  • In 2006, an epidemic acute hemorrhagic conjunctivitis (involving more than 200,000 people) was reported as occurring in Brazil.[9]

References

  1. 1.0 1.1 Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G (2008). "Neonatal conjunctivitis - a review". Malays Fam Physician. 3 (2): 77–81. PMC 4170304. PMID 25606121.
  2. 2.0 2.1 "Reports from the obstetrical clinic in Leipzig. Prevention of eye inflammation in the newborn". Am J Dis Child. 121 (1): 3–4. 1971. PMID 5543850.
  3. Weeks JE (1996). "The bacillus of acute conjunctival catarrh, or 'pink eye'. 1886". Arch Ophthalmol. 114 (12): 1510–1. PMID 8953986.
  4. HOGAN MJ (1952). "Atopic keratoconjunctivitis". Trans Am Ophthalmol Soc. 50: 265–81. PMC 1313175. PMID 13102561.
  5. Watson S, Tullo AB, Carley F (2002). "Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens". Br J Ophthalmol. 86 (4): 485–6. PMC 1771108. PMID 11914237.
  6. Nelson JD (1989). "Superior limbic keratoconjunctivitis (SLK)". Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.
  7. Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.
  8. Centers for Disease Control and Prevention (2004) https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5328a2.htm Accessed on June 24, 2016
  9. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC) (2010). "Sexually transmitted diseases treatment guidelines, 2010". MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459.


Template:WikiDoc Sources